Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

A Harvard Medical School study showed OpenAI’s o1 model exceeded ER physicians in real-world diagnostic and treatment planning accuracy. ICTER researchers introduced an atomic-resolution, ...

Patients were stratified to cohort A (unspecified tumors) or cohort B (rare genomic alterations). The TARGET-CRM design permits cohort B patients to immediately enroll at one dose level below the ...

Rendered model showing a complex 3D structure made up of thousands of repeating microscopic patterns. By teaching an AI model to predict the behavior of these patterns, the Drexel team can design ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.